OA12686A - Fast dissolving tablets of cyclooxygenase-2 enzymeinhibitors. - Google Patents

Fast dissolving tablets of cyclooxygenase-2 enzymeinhibitors. Download PDF

Info

Publication number
OA12686A
OA12686A OA1200300219A OA1200300219A OA12686A OA 12686 A OA12686 A OA 12686A OA 1200300219 A OA1200300219 A OA 1200300219A OA 1200300219 A OA1200300219 A OA 1200300219A OA 12686 A OA12686 A OA 12686A
Authority
OA
OAPI
Prior art keywords
tablet according
cox
group
tablet
inhibitor
Prior art date
Application number
OA1200300219A
Other languages
English (en)
Inventor
Deepak Murpani
Vinod Kumar Arora
Rajiv Malik
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of OA12686A publication Critical patent/OA12686A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
OA1200300219A 2001-02-27 2002-02-27 Fast dissolving tablets of cyclooxygenase-2 enzymeinhibitors. OA12686A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN189DE2001 2001-02-27

Publications (1)

Publication Number Publication Date
OA12686A true OA12686A (en) 2006-06-21

Family

ID=11097035

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200300219A OA12686A (en) 2001-02-27 2002-02-27 Fast dissolving tablets of cyclooxygenase-2 enzymeinhibitors.

Country Status (9)

Country Link
EP (1) EP1367994A2 (fr)
AU (1) AU2002236120A1 (fr)
CZ (1) CZ20032568A3 (fr)
HU (1) HUP0400098A2 (fr)
IS (1) IS6932A (fr)
OA (1) OA12686A (fr)
PL (1) PL363771A1 (fr)
SK (1) SK11802003A3 (fr)
WO (1) WO2002067894A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815937B2 (en) 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物
TR200301552A1 (tr) * 2003-09-18 2005-10-21 Nobel İlaç Sanayi̇ Ve Ti̇caret A. Ş. Rofekoksib' in yeni oral farmakolojik formülasyonları.
GB0724707D0 (en) * 2007-12-19 2008-01-30 Burke Michael H A process for the preparation of an orally administered unit dose tablet
US10350171B2 (en) 2017-07-06 2019-07-16 Dexcel Ltd. Celecoxib and amlodipine formulation and method of making the same
CN108653225B (zh) * 2018-08-15 2021-01-08 湖北舒邦药业有限公司 一种尼美舒利制剂及其制备方法
CN112569178B (zh) * 2020-12-29 2022-09-09 南京百泽医药科技有限公司 一种帕瑞昔布药物组合物制备方法及用作舌下制剂的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK74396A3 (en) * 1995-06-13 1997-04-09 American Home Prod Organoleptically acceptable oral pharmaceutical compositions
EP0945134A1 (fr) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Nouvelles formes galeniques du meloxicam pour administration par voie orale
WO2001085134A1 (fr) * 2000-05-12 2001-11-15 Emcure Pharmaceuticals Ltd Compositions pharmaceutiques solides et procede de production de comprimes se dissolvant dans la bouche

Also Published As

Publication number Publication date
HUP0400098A2 (hu) 2004-04-28
SK11802003A3 (sk) 2004-06-08
CZ20032568A3 (cs) 2004-04-14
PL363771A1 (en) 2004-11-29
EP1367994A2 (fr) 2003-12-10
IS6932A (is) 2003-08-27
WO2002067894A2 (fr) 2002-09-06
AU2002236120A1 (en) 2002-09-12
WO2002067894A3 (fr) 2002-12-19

Similar Documents

Publication Publication Date Title
US20030161875A1 (en) Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors
JP4284017B2 (ja) 固形製剤
JP4965130B2 (ja) 乾式直打速崩壊性錠剤
JP5342028B2 (ja) 口腔内崩壊錠
BR112014026292B1 (pt) Comprimido oralmente desintegrável, e, processo para a produção de um comprimido oralmente desintegrável
US20060100214A1 (en) Fast dissolving and taste masked oral dosage form comprising sildenafil
CN110475544B (zh) 包含氨基甲酸酯化合物的口腔崩解片
JP2008285434A (ja) 口腔内速崩壊錠
WO2008079342A2 (fr) Comprimés à désintégration par voie orale: composition utilisée et méthode de fabrication orale
JP2004175796A (ja) 排尿障害治療用口腔内崩壊製剤
US20110046115A1 (en) Mirtazapine Solid Dosage Forms
JP4090997B2 (ja) ペリンドプリルの口内分散性薬剤組成物
OA12686A (en) Fast dissolving tablets of cyclooxygenase-2 enzymeinhibitors.
KR102191468B1 (ko) 초고속 붕괴 정제 및 그 제조 방법
AU2003253198A1 (en) Bicifadine formulation
RU2426529C2 (ru) Орально распадающийся порошок, содержащий цилостазол и маннит
JP4814636B2 (ja) ビグアナイド系薬物の内服製剤
AU2011379627B2 (en) Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof
JP5168712B2 (ja) ナテグリニド含有製剤
JP6513702B2 (ja) 超速崩壊錠剤及びその製造方法
JPWO2020090970A1 (ja) 抗腫瘍剤を含む医薬組成物
JP5062872B2 (ja) 不快な味を低減した口腔内崩壊錠剤
JP2008162989A (ja) 口腔内速崩壊錠
JPWO2011049122A1 (ja) プラバスタチンナトリウム口腔内速崩壊錠及びその製造方法
AU777234B2 (en) Pharmaceutical effervescent formulation containing metamizol